Proinflammatory Cytokines in Heart Failure: Double-edged Swords

Overview

Journal Heart Fail Rev

Date 2010 Apr 21

PMID 20405319

Citations 77

Authors

Mona Hedayat

Mohammad Jafar Mahmoudi

Noel R Rose

Nima Rezaei

Affiliations

Soon will be listed here.

Abstract

Increased circulating and intracardiac levels of proinflammatory cytokines have been associated with chronic heart failure. Following an initial insult, the increased production of proinflammatory cytokines, including TNF-α, IL-6, IL-1, and IL-18, jeopardizes the surrounding tissue through propagation of the inflammatory response and direct effects on the cardiac myocyte structure and function. Cardiac myocyte hypertrophy, contractile dysfunction, cardiac myocyte apoptosis, and extracellular matrix remodeling contribute enormously to the development and progression of chronic heart failure. Despite the identification of efficacious pharmacological regimens and introduction of mechanical interventions, chronic heart failure remains among the leading causes of mortality worldwide. To introduce novel therapeutic strategies that modulate the inflammatory response in the context of the failing heart, it is of prime importance to determine the contributions of TNF-α, IL-6, IL-1, and IL-18 in mediating cardiac adaptive and maladaptive responses, as well as delineating their downstream intracellular signaling pathways and their potential therapeutic implications.

Citing Articles

Molecular Mechanisms Underlying Heart Failure and Their Therapeutic Potential.

Fonseka O, Gare S, Chen X, Zhang J, Alatawi N, Ross C Cells. 2025; 14(5).

PMID: 40072053 PMC: 11899429. DOI: 10.3390/cells14050324.

Novel Immunohistochemical and Morphological Approaches in a Retrospective Study of Post-Mortem Myocarditis.

Neagu O, Chirica V, Luca L, Bosa M, Tita A, Ceausu M Medicina (Kaunas). 2024; 60(8).

PMID: 39202593 PMC: 11356551. DOI: 10.3390/medicina60081312.

Cytokeratin 18 as a Novel Biomarker in Patients with Hypertrophic Cardiomyopathy.

Fragkiadakis K, Ktena N, Kalantidou A, Dermitzaki E, Anastasiou I, Papathanassiou S Cells. 2024; 13(16.

PMID: 39195218 PMC: 11352956. DOI: 10.3390/cells13161328.

Homotherapy for Heteropathy: A Molecular Mechanism of Poria Sini Decoction for Treatment of Liver Cancer and Chronic Heart Failure.

Zhao Z, Yue H, Cui X Evid Based Complement Alternat Med. 2024; 2024:9958258.

PMID: 38711438 PMC: 11073853. DOI: 10.1155/2024/9958258.

Higher C-Reactive Protein to Albumin Ratio Portends Long-Term Mortality in Patients with Chronic Heart Failure and Reduced Ejection Fraction.

Tanik V, Akdeniz E, Cinar T, Simsek B, Inan D, Kivrak A Medicina (Kaunas). 2024; 60(3).

PMID: 38541167 PMC: 10972301. DOI: 10.3390/medicina60030441.

References

Stambolic V, Suzuki A, de la Pompa J, Brothers G, Mirtsos C, Sasaki T . Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 1998; 95(1):29-39. DOI: 10.1016/s0092-8674(00)81780-8. View

Reddy V, Harskamp R, van Ginkel M, Calhoon J, Baisden C, Kim I . Interleukin-18 stimulates fibronectin expression in primary human cardiac fibroblasts via PI3K-Akt-dependent NF-kappaB activation. J Cell Physiol. 2007; 215(3):697-707. DOI: 10.1002/jcp.21348. View

Sliwa K, Woodiwiss A, Candy G, Badenhorst D, Libhaber C, Norton G . Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol. 2002; 90(10):1118-22. DOI: 10.1016/s0002-9149(02)02779-0. View

Netea M, Kullberg B, Verschueren I, van der Meer J . Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta. Eur J Immunol. 2000; 30(10):3057-60. DOI: 10.1002/1521-4141(200010)30:10<3057::AID-IMMU3057>3.0.CO;2-P. View

Ono K, Matsumori A, SHIOI T, Furukawa Y, Sasayama S . Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation. 1998; 98(2):149-56. DOI: 10.1161/01.cir.98.2.149. View

Zha J, Harada H, Yang E, Jockel J, Korsmeyer S . Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell. 1996; 87(4):619-28. DOI: 10.1016/s0092-8674(00)81382-3. View

Nishikawa K, Yoshida M, Kusuhara M, Ishigami N, Isoda K, Miyazaki K . Left ventricular hypertrophy in mice with a cardiac-specific overexpression of interleukin-1. Am J Physiol Heart Circ Physiol. 2006; 291(1):H176-83. DOI: 10.1152/ajpheart.00269.2005. View

Saito M, Yoshida K, Hibi M, Taga T, Kishimoto T . Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo. J Immunol. 1992; 148(12):4066-71. View

Condorelli G, Drusco A, Stassi G, Bellacosa A, Roncarati R, Iaccarino G . Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci U S A. 2002; 99(19):12333-8. PMC: 129445. DOI: 10.1073/pnas.172376399. View

10.

Liao Z, Brar B, Cai Q, Stephanou A, OLeary R, Pennica D . Cardiotrophin-1 (CT-1) can protect the adult heart from injury when added both prior to ischaemia and at reperfusion. Cardiovasc Res. 2002; 53(4):902-10. DOI: 10.1016/s0008-6363(01)00531-4. View

11.

Nakano M, Knowlton A, Yokoyama T, LESSLAUER W, Mann D . Tumor necrosis factor-alpha-induced expression of heat shock protein 72 in adult feline cardiac myocytes. Am J Physiol. 1996; 270(4 Pt 2):H1231-9. DOI: 10.1152/ajpheart.1996.270.4.H1231. View

12.

Hirota H, Chen J, Betz U, Rajewsky K, Gu Y, ROSS Jr J . Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell. 1999; 97(2):189-98. DOI: 10.1016/s0092-8674(00)80729-1. View

13.

Wollert K, Taga T, Saito M, Narazaki M, Kishimoto T, Glembotski C . Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem. 1996; 271(16):9535-45. DOI: 10.1074/jbc.271.16.9535. View

14.

Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo J . Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med. 1996; 183(3):949-58. PMC: 2192364. DOI: 10.1084/jem.183.3.949. View

15.

Oh H, Fujio Y, Kunisada K, Hirota H, Matsui H, Kishimoto T . Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes. J Biol Chem. 1998; 273(16):9703-10. DOI: 10.1074/jbc.273.16.9703. View

16.

Morel J, Park C, Zhu K, Kumar P, Ruth J, Koch A . Signal transduction pathways involved in rheumatoid arthritis synovial fibroblast interleukin-18-induced vascular cell adhesion molecule-1 expression. J Biol Chem. 2002; 277(38):34679-91. DOI: 10.1074/jbc.M206337200. View

17.

Li Y, Kadokami T, Wang P, McTiernan C, Feldman A . MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure. Am J Physiol Heart Circ Physiol. 2002; 282(3):H983-9. DOI: 10.1152/ajpheart.00233.2001. View

18.

Li Y, Feng Y, Kadokami T, McTiernan C, Draviam R, Watkins S . Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. Proc Natl Acad Sci U S A. 2000; 97(23):12746-51. PMC: 18835. DOI: 10.1073/pnas.97.23.12746. View

19.

Goldhaber J, Kim K, Natterson P, Lawrence T, Yang P, Weiss J . Effects of TNF-alpha on [Ca2+]i and contractility in isolated adult rabbit ventricular myocytes. Am J Physiol. 1996; 271(4 Pt 2):H1449-55. DOI: 10.1152/ajpheart.1996.271.4.H1449. View

20.

Wen Z, Zhong Z, Darnell Jr J . Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 1995; 82(2):241-50. DOI: 10.1016/0092-8674(95)90311-9. View